Michael Bates, M.D.

Michael BatesDr. Bates has been developing molecular diagnostics for Oncology applications since 2004, when he headed up Clinical Research for Oncology at Monogram Biosciences/ViroLogic.   That work was preceded by and overlapped with a focus on phenotypic and genotypic anti-HIV drug resistance diagnostics at ViroLogic, and HIV and HCV therapeutics at Roche. Dr. Bates has been developing the pipeline of Oncology applications for the GeneXpert at Cepheid since 2011.

Prior to industry, Dr. Bates trained in Internal Medicine at UCSF, Cardiovascular Diseases at Duke, and Infectious Diseases at the University of Washington, with research training in Tumor Immunology at the Dana-Farber Cancer Institute in Boston, Molecular Genetics at the University of Texas Southwestern Medical School in Dallas, and Virology at the Fred Hutchinson Cancer Research Center in Seattle.